Successful reduction of ACTH secretion in a case of intractable Cushing’s disease with pituitary Crooke’s cell adenoma by combined modality therapy including temozolomide-Reference-Cited by-同舟云学术

Successful reduction of ACTH secretion in a case of intractable Cushing’s disease with pituitary Crooke’s cell adenoma by combined modality therapy including temozolomide

Published:2019 Issue:8 Volume:66 Page:701-708
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Tanaka Sayuri¹,Yamamoto Masahiro¹,Morita Miwa¹,Takeno Ayumu¹,Kanazawa Ippei¹,Yamaguchi Toru¹,Yamada Shozo²,Inoshita Naoko³,Oki Yutaka⁴,Kurosaki Masamichi⁵,Sugimoto Toshitsugu¹

Affiliation:

1. Internal Medicine 1, Shimane University Faculty of Medicine, Izumo 693-8501, Japan

2. Endocrine Center, Division of Hypothalamic & Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan

3. Department of Pathology, Toranomon Hospital, Tokyo 105-8470, Japan

4. Second Division Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan

5. Division of Neurosurgery, Department of Brain and Neurosciences, Faculty of Medicine Tottori University, Yonago 683-8504, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/66/8/66_EJ18-0547/_pdf

Reference22 articles.

1. 1 George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF Jr, et al. (2003) Crooke’s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 27: 1330–1336.

2. 2 Takeshita A, Inoshita N, Taguchi M, Okuda C, Fukuhara N, et al. (2009) High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing’s disease. Eur J Endocrinol 161: 553–559.

3. 3 Yamakita N, Murai T, Oki Y, Matsuhisa T, Hirata T, et al. (2001) Adrenal insufficiency after incomplete resection of pituitary macrocorticotropinoma of Cushing’s disease: role of high molecular weight ACTH. Endocr J 48: 43–51.

4. 4 Yonemura K, Yasuda H, Fujigaki Y, Oki Y, Hishida A (2003) Adrenal insufficiency due to isolated adrenocorticotropin deficiency complicated by autosomal recessive polycystic kidney disease. Ren Fail 25: 485–492.

5. 5 McCormack AI, Wass JA, Grossman AB (2011) Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status. Eur J Clin Invest 41: 1133–1148.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis;World Neurosurgery;2023-12

2. Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series;Expert Review of Endocrinology & Metabolism;2023-03-04

3. Endoscopic Endonasal Surgery for Uncommon Pathologies of the Sellar and Parasellar Regions;Advances and Technical Standards in Neurosurgery;2023

4. Temozolomide in aggressive pituitary tumours and pituitary carcinomas;Best Practice & Research Clinical Endocrinology & Metabolism;2022-12

5. Pathology of Crooke Cells in the Human Pituitaries: A Timely Review;Applied Immunohistochemistry & Molecular Morphology;2022-10-17